IRVING, TX, Dec. 3, 2020—McKesson Corporation today announced the launch of Ontada, an oncology technology and insights business designed to support innovation, acceleration, and evidence
generation to drive better outcomes for patients with cancer.
“Ontada reflects McKesson’s continued commitment and investment in the oncology community,” said Brian Tyler, chief executive officer, McKesson. “As one of the largest healthcare companies, McKesson is at the center of care delivery, which provides a
unique perspective on the complexities of cancer care and the growing needs among providers and life sciences companies. With the launch of Ontada, we can now build upon our differentiated assets in oncology and deliver innovative solutions that help
improve patient outcomes.”
Building on McKesson’s long history in community oncology, Ontada combines its real-world data and research capabilities with a leading suite of technologies for oncology clinicians – including the iKnowMed℠ electronic health record system and Clear Value Plus℠ regimen support tool – as well as a connection to a national community oncology network
to transform the fight against cancer.
Ontada is uniquely positioned to advance cancer care by enabling deep collaboration between life sciences companies and oncology providers. Its team of data scientists and oncology experts help life sciences companies leverage evidence-based data and
insights to accelerate innovation and improve cancer therapy, while empowering providers to deliver the best care and improved outcomes for patients. Ontada will provide a number of real clinical benefits to enable life sciences companies to help
bring breakthrough oncology products to market sooner and better support the entire patient journey.
Through its deep connections to oncology practices, Ontada can help expand the reach of therapies with engagement and education opportunities with physicians. The benefits that Ontada can offer to providers are further enhanced through its strong relationship
with McKesson’s The US Oncology Network, as well as other community oncology practices.
“At The US Oncology Network, we collaborate with practices to leverage evidence-driven care to deliver better patient outcomes,” said Michael Seiden, M.D., Ph.D., president, The US Oncology Network. “We’re thrilled to have Ontada as a technology partner
who shares our vision and will provide us with the tools and insights we need to put patients first.”
Ontada is an oncology technology and insights business dedicated to transforming the fight against cancer. Part of McKesson
Corporation, Ontada was founded on the core belief that precise insights – delivered exactly at the point of need – can save more patients’ lives. We connect the full patient journey by combining technologies used by The US Oncology Network and other community oncology providers with real-world data and research relied on by all top 15 global life sciences companies. Our work helps accelerate innovation and power the future
of cancer care. For more information, visit ontada.com or follow @OntadaOncology.
About The US Oncology Network
Every day, The US Oncology Network (The Network) helps more than 1,380 independent physicians deliver value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared
expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes. The Network provides practices with access to coordinated resources, best business practices, and the experience, infrastructure and support
of McKesson Corporation. This collaboration allows the providers in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices. The Network is committed to the -success of independent practices, everywhere.
About McKesson Corporation
McKesson Corporation is a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions. McKesson partners with pharmaceutical manufacturers, providers, pharmacies,
governments and other organizations in healthcare to help provide the right medicines, medical products and healthcare services to the right patients at the right time, safely and cost-effectively. United by our ICARE shared principles, our employees
work every day to innovate and deliver opportunities that make our customers and partners more successful — all for the better health of patients. McKesson has been named a “Most Admired Company”
in the healthcare wholesaler category by FORTUNE, a “Best Place to Work” by the Human Rights Campaign Foundation,
and a top military-friendly company by Military Friendly. For more information, visit www.mckesson.com.
Annabelle Baxter, External Communications
General and Business Press